ArticleJournal of gastrointestinal oncology2026
Organ-specific response to atezolizumab + bevacizumab combination therapy for unresectable hepatocellular carcinoma with extrahepatic metastases: a retrospective cohort study.
Akihiro Dejima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.